Cybin holds annual, special shareholder meeting; name change set for Oct. 1
Bitget2026/09/23 10:02- Cybin held its annual and special shareholder meeting on Sept. 22, 2026.
- Shareholders backed a plan to set the board size at eight directors.
- Investors also endorsed changing the legal name to Helus Pharma, with the change set to take effect Oct. 1, 2026.
- Zeifmans was appointed as auditor until the next annual shareholder meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
